Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5
NCT00652002 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 450
Last updated 2011-01-24
Summary
The purpose of this study is to compare Symbicort with budesonide alone and with formoterol alone in the treatment of asthma in adolescents and adults
Conditions
Interventions
- DRUG
-
budesonide/formoterol
- DRUG
-
budesonide
- DRUG
-
formoterol
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Catherine Bonuccelli · AstraZeneca
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-07-31
- Completion
- 2004-01-31
More Related Trials
-
Effect of Symbicort on GR Localisation in Asthma
NCT00159263 ·Status: COMPLETED ·Phase: NA
-
Long-Term Safety of Symbicort in Asthmatic Children - SAPLING
NCT00646529 ·Status: COMPLETED ·Phase: PHASE3
-
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
NCT02091986 ·Status: COMPLETED ·Phase: PHASE3
-
SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults
NCT00238784 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants
NCT02495168 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Investigate the Efficacy of Symbicort® SMART.
NCT00839800 ·Status: COMPLETED ·Phase: PHASE3
-
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
NCT01444430 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma
NCT00255255 ·Status: COMPLETED ·Phase: PHASE3
-
STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent Asthma
NCT00252824 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Safety and Efficacy of Symbicort® pMDI, With or Without Spacer, in Children (6-11 Years) With Asthma
NCT00536913 ·Status: COMPLETED ·Phase: PHASE3
-
Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults
NCT00385593 ·Status: TERMINATED ·Phase: PHASE3
-
Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
NCT00319306 ·Status: COMPLETED ·Phase: PHASE3
-
Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans
NCT00702325 ·Status: COMPLETED ·Phase: PHASE4
-
Use of Symbicort or Pulmicort to Treat Viral-mediated Asthma Exacerbations
NCT01218399 ·Status: COMPLETED ·Phase: NA
-
Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients
NCT03015259 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma.
NCT02149199 ·Status: COMPLETED ·Phase: PHASE3
-
SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent Asthma
NCT00290264 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing Symbicort® As-Needed or Bricanyl As-Needed or Pulmicort® Once Daily + Bricanyl As-Needed in Asthma Patients
NCT00989833 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®
NCT00244608 ·Status: COMPLETED ·Phase: PHASE3
-
MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and Adults
NCT00242411 ·Status: COMPLETED ·Phase: PHASE4
-
Gemini Symbicort pMDI
NCT00646516 ·Status: COMPLETED ·Phase: PHASE3
-
Symbicort Onset of Action 2
NCT00646009 ·Status: COMPLETED ·Phase: PHASE3
-
SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults
NCT00259792 ·Status: COMPLETED ·Phase: PHASE3
-
Symbicort Onset of Action 1
NCT00646620 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma
NCT02224157 ·Status: COMPLETED ·Phase: PHASE3